盛禾生物-B(02898)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02898 盛禾生物-B

休市中 02-06 15:08:08

6.350

+0.130

+2.09%

最高6.400	最低6.400	成交量2,800
今开6.400	昨收6.220	日振幅0.00%
总市值9.97亿	流通市值9.95亿	总股本1.57亿
成交额1.79万	换手率0.00%	流通股本1.57亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02898","market":"HK","secType":"STK","nameCN":"盛禾生物-B","latestPrice":6.35,"timestamp":1770361688577,"preClose":6.22,"halted":0,"volume":2800,"delay":0,"changeRate":0.020900321543408342,"floatShares":156666800,"shares":157000000,"eps":-0.623669,"marketStatus":"休市中","change":0.13,"latestTime":"02-06 15:08:08","open":6.4,"high":6.4,"low":6.4,"amount":17920,"amplitude":0,"askPrice":6.34,"askSize":1200,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.59602,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770600600000},"marketStatusCode":7,"adr":0,"listingDate":1716480000000,"exchange":"SEHK","adjPreClose":6.22,"openAndCloseTimeList":[[1770341400000,1770350400000],[1770354000000,1770364800000]],"volumeRatio":0,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02898","defaultTab":"news","newsList":[{"id":"1161358124","title":"盛禾生物控股（02898）公布2026年1月月报，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1161358124","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161358124?lang=zh_cn&edition=full","pubTime":"2026-02-04 17:36","pubTimestamp":1770197786,"startTime":"0","endTime":"0","summary":"盛禾生物控股有限公司近日发布2026年1月证券变动月报表。公告日期为2026年2月4日，报告期覆盖至2026年1月31日。根据公告显示，公司法定股本维持为2亿股，面值每股0.0005美元，注册资本总额100,000美元；截至本月底已发行股份总数为156,666,800股，与上月底一致。截至报告期末，股本结构未发生实质变动，公众持股量符合适用的香港联交所上市规则要求。公告由公司主席兼执行董事张峰签署。公司表示将持续遵守香港联交所《上市规则》及相关法规之规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02898"],"gpt_icon":0},{"id":"2606322246","title":"盛禾生物委任姜晓玲为CEO兼首席科学官，履历涵盖金斯瑞、优科制药","url":"https://stock-news.laohu8.com/highlight/detail?id=2606322246","media":"瑞财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606322246?lang=zh_cn&edition=full","pubTime":"2026-01-26 18:30","pubTimestamp":1769423411,"startTime":"0","endTime":"0","summary":"瑞财经 刘治颖1月23日，盛禾生物-B公告，执行董事姜晓玲已获委任为公司首席执行官兼首席科学官，自2026年1月23日起生效。资料显示，姜晓玲，自2020年2月起加入集团，担任盛禾（中国）生物制药的副总经理及研发负责人。2024年，姜晓玲获得薪金及其他福利29.3万元，退休福利计划供款1万元，酌情花红4.5万元及股权支付236.2万元。2025年上半年，盛禾生物其他收入为503.5万元，同比增长182.55%；期内亏损为3819.9万元，上年同期亏损3607.7万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126183034a4573dc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126183034a4573dc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01548","HK0000306701.USD","BK1141","02898","BK1574","BK1583","BK1191","HK0000320223.HKD","BK1161","BK1576","HK0000306685.HKD","01477","HK0000320264.USD"],"gpt_icon":0},{"id":"2605477190","title":"盛禾生物-B(02898)：姜晓玲获委任为首席执行官兼首席科学官","url":"https://stock-news.laohu8.com/highlight/detail?id=2605477190","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605477190?lang=zh_cn&edition=full","pubTime":"2026-01-23 20:32","pubTimestamp":1769171578,"startTime":"0","endTime":"0","summary":"智通财经APP讯，盛禾生物-B(02898)发布公告，执行董事姜晓玲女士已获委任为公司首席执行官兼首席科学官，自2026年1月23日起生效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1396879.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02898","BK1161"],"gpt_icon":0},{"id":"2605244011","title":"盛禾生物-B盘中异动 早盘股价大跌10.33%报6.250港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605244011","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605244011?lang=zh_cn&edition=full","pubTime":"2026-01-23 09:58","pubTimestamp":1769133505,"startTime":"0","endTime":"0","summary":"2026年01月23日早盘09时58分，盛禾生物-B股票出现波动，股价快速跳水10.33%。截至发稿，该股报6.250港元/股，成交量1800股，换手率0.00%，振幅0.14%。资金方面，该股资金流入0港元，流出1.1266万港元。盛禾生物-B股票所在的生物技术行业中，整体涨幅为0.92%。IAH0968是一种抗体依赖性细胞介导的细胞毒性增强型单克隆抗体,IAP0971及IAE0972均为抗体细胞因子。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123095825953dfe79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123095825953dfe79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02898"],"gpt_icon":0},{"id":"2604368161","title":"盛禾生物-B(02898)：殷刘松辞任执行董事、首席执行官兼首席科学官","url":"https://stock-news.laohu8.com/highlight/detail?id=2604368161","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604368161?lang=zh_cn&edition=full","pubTime":"2026-01-19 21:10","pubTimestamp":1768828219,"startTime":"0","endTime":"0","summary":"智通财经APP讯，盛禾生物-B(02898)发布公告，殷刘松博士已于2026年1月19日提出辞任公司执行董事、首席执行官兼首席科学官，自2026年2月28日起生效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1394730.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"盛禾生物-B(02898)：殷刘松辞任执行董事、首席执行官兼首席科学官","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02898"],"gpt_icon":0},{"id":"1111364007","title":"盛禾生物控股（02898）更新2025年12月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1111364007","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111364007?lang=zh_cn&edition=full","pubTime":"2026-01-02 16:35","pubTimestamp":1767342926,"startTime":"0","endTime":"0","summary":"盛禾生物控股有限公司于2026年1月2日公布2025年12月的股份变动月报表。报告显示，截至2025年12月31日，公司注册股本维持在200,000,000股，每股面值USD 0.0005，合计注册股本USD 100,000，未见任何增减。同时，公告显示，本月无任何股份期权、可换股票据或其他相关激励计划的变动。整体而言，截至2025年12月31日，盛禾生物控股有限公司股本总数保持不变，公司声明遵守了香港联交所《上市规则》及相关法律规定。上述月报由公司主席兼执行董事张峰签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02898"],"gpt_icon":0},{"id":"2588046853","title":"盛禾生物-B盘中异动 早盘急速上涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588046853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588046853?lang=zh_cn&edition=full","pubTime":"2025-12-03 10:38","pubTimestamp":1764729509,"startTime":"0","endTime":"0","summary":"2025年12月03日早盘10时38分，盛禾生物-B股票出现异动，股价大幅拉升5.07%。截至发稿，该股报7.250港元/股，成交量4400股，换手率0.00%，振幅2.46%。盛禾生物-B股票所在的生物技术行业中，整体跌幅为1.46%。其相关个股中，中生北控生物科技、盛禾生物-B、嘉和生物-B涨幅较大，振幅较大的相关个股有中生北控生物科技、华康生物医学、歌礼制药-B，振幅分别为14.98%、10.87%、10.30%。IAH0968是一种抗体依赖性细胞介导的细胞毒性增强型单株抗体,IAP0971及IAE0972均为抗体细胞激素。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203103829a7206997&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203103829a7206997&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02898"],"gpt_icon":0},{"id":"2586267959","title":"盛禾生物-B11月26日主力净流出12.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2586267959","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586267959?lang=zh_cn&edition=full","pubTime":"2025-11-26 16:15","pubTimestamp":1764144922,"startTime":"0","endTime":"0","summary":"11月26日, 盛禾生物-B股价跌1.57%，报收6.88元，成交金额25.2万元，换手率0.02%，振幅10.30%，量比8.80。盛禾生物-B今日主力资金净流出12.8万元，上一交易日主力净流出0万元。该股近5个交易日下跌8.14%，主力资金累计净流出12.8万元；近20日主力资金累计净流出12.8万元，其中净流出天数为1日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112616165197804a86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112616165197804a86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02898","BK1161"],"gpt_icon":0},{"id":"2586474417","title":"盛禾生物-B盘中异动 急速下挫5.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586474417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586474417?lang=zh_cn&edition=full","pubTime":"2025-11-25 15:55","pubTimestamp":1764057326,"startTime":"0","endTime":"0","summary":"2025年11月25日临近收盘15时55分，盛禾生物-B股票出现异动，股价大幅下挫5.92%。盛禾生物-B股票所在的生物技术行业中，整体跌幅为1.17%。其相关个股中，拨康视云-B、绿竹生物-B、中生北控生物科技涨幅较大，振幅较大的相关个股有中生北控生物科技、拨康视云-B、华康生物医学，振幅分别为22.54%、20.38%、16.90%。该公司拥有三种核心产品,分别为IAH0968、IAP0971及IAE0972。IAH0968是一种抗体依赖性细胞介导的细胞毒性增强型单株抗体,IAP0971及IAE0972均为抗体细胞激素。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125155526977e22df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125155526977e22df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02898","BK1161"],"gpt_icon":0},{"id":"2579944270","title":"盛禾生物-B盘中异动 大幅下跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579944270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579944270?lang=zh_cn&edition=full","pubTime":"2025-10-28 15:29","pubTimestamp":1761636586,"startTime":"0","endTime":"0","summary":"2025年10月28日下午盘15时29分，盛禾生物-B股票出现异动，股价快速下挫5.19%。盛禾生物-B股票所在的生物技术行业中，整体跌幅为2.28%。其相关个股中，华康生物医学、拨康视云-B、同源康医药-B涨幅较大，振幅较大的相关个股有永泰生物-B股权、圣诺医药-B、轩竹生物-B，振幅分别为19.70%、14.95%、11.90%。该公司拥有三种核心产品,分别为IAH0968、IAP0971及IAE0972。IAH0968是一种抗体依赖性细胞介导的细胞毒性增强型单株抗体,IAP0971及IAE0972均为抗体细胞激素。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102815294697462b83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102815294697462b83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02898"],"gpt_icon":0},{"id":"2578647266","title":"盛禾生物-B盘中异动 急速跳水7.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578647266","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578647266?lang=zh_cn&edition=full","pubTime":"2025-10-27 10:55","pubTimestamp":1761533752,"startTime":"0","endTime":"0","summary":"2025年10月27日早盘10时55分，盛禾生物-B股票出现异动，股价快速跳水7.40%。截至发稿，该股报7.130港元/股，成交量200股，换手率0.00%，振幅0.00%。盛禾生物-B股票所在的生物技术行业中，整体涨幅为2.37%。其相关个股中，百奥赛图-B、华康生物医学、昭衍新药涨幅较大，振幅较大的相关个股有永泰生物-B股权、北海康成-B、华康生物医学，振幅分别为21.74%、13.04%、11.32%。IAH0968是一种抗体依赖性细胞介导的细胞毒性增强型单株抗体,IAP0971及IAE0972均为抗体细胞激素。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251027105552a6cfc3bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251027105552a6cfc3bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02898","BK1161"],"gpt_icon":0},{"id":"2577353078","title":"盛禾生物-B盘中异动 大幅下挫5.62%报7.220港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577353078","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577353078?lang=zh_cn&edition=full","pubTime":"2025-10-22 11:48","pubTimestamp":1761104891,"startTime":"0","endTime":"0","summary":"2025年10月22日临近午盘11时48分，盛禾生物-B股票出现波动，股价大幅跳水5.62%。截至发稿，该股报7.220港元/股，成交量5200股，换手率0.00%，振幅9.93%。盛禾生物-B股票所在的生物技术行业中，整体跌幅为1.12%。其相关个股中，轩竹生物-B、药捷安康-B、华康生物医学涨幅较大，振幅较大的相关个股有药捷安康-B、轩竹生物-B、华康生物医学，振幅分别为27.85%、25.71%、22.58%。IAH0968是一种抗体依赖性细胞介导的细胞毒性增强型单株抗体,IAP0971及IAE0972均为抗体细胞激素。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022114811a6c71271&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022114811a6c71271&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02898","BK1161"],"gpt_icon":0},{"id":"2577984830","title":"盛禾生物-B10月20日主力净流入29.8万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2577984830","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577984830?lang=zh_cn&edition=full","pubTime":"2025-10-20 16:15","pubTimestamp":1760948144,"startTime":"0","endTime":"0","summary":"10月20日, 盛禾生物-B股价涨3.44%，报收7.81元，成交金额30.4万元，换手率0.02%，振幅0.13%，量比5.68。盛禾生物-B今日主力资金净流入29.8万元，上一交易日主力净流出0万元。该股近5个交易日上涨2.76%，主力资金累计净流入29.8万元；近20日主力资金累计净流入13.8万元，其中净流入天数为1日。该股主力净额占比0.02%，港股市场排名221/2681。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510201620009738551c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510201620009738551c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02898","BK1161"],"gpt_icon":0},{"id":"2574479415","title":"盛禾生物ISH0613申报IND","url":"https://stock-news.laohu8.com/highlight/detail?id=2574479415","media":"佰傲谷BioValley","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574479415?lang=zh_cn&edition=full","pubTime":"2025-10-12 12:02","pubTimestamp":1760241759,"startTime":"0","endTime":"0","summary":"近日，根据CDE官网公示，盛禾生物ISH0613已经向NMPA申报IND，并得到受理。根据该公司官网显示，ISH0613这款管线的靶点未知，适应症为SLE，靶向效果可抑制B细胞激活及IFNα分泌，采用的是该公司的抗体细胞因子融合蛋白平台。根据招股书显示，该药物原定于2024年Q2向NMPA提交IND，如今延期了一年。本文简单推测ISH0613可能是一款BAFF-R/IL-10融合蛋白。在SLE患者中，BAFF水平显著升高，导致B细胞过度活化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251012123159a45b6f1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251012123159a45b6f1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02898","BK1161"],"gpt_icon":0},{"id":"2570059976","title":"盛禾生物-B盘中异动 股价大跌5.61%报7.740港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2570059976","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570059976?lang=zh_cn&edition=full","pubTime":"2025-09-24 13:11","pubTimestamp":1758690680,"startTime":"0","endTime":"0","summary":"2025年09月24日下午盘13时11分，盛禾生物-B股票出现异动，股价快速下跌5.61%。截至发稿，该股报7.740港元/股，成交量800股，换手率0.00%，振幅5.49%。资金方面，该股资金流入1638港元，流出4644港元。盛禾生物-B股票所在的生物技术行业中，整体跌幅为1.10%。该公司拥有三种核心产品,分别为IAH0968、IAP0971及IAE0972。IAH0968是一种抗体依赖性细胞介导的细胞毒性增强型单株抗体,IAP0971及IAE0972均为抗体细胞激素。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092413112097a63bf8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092413112097a63bf8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02898"],"gpt_icon":0},{"id":"2568253753","title":"盛禾生物-B09月19日主力净流出16.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2568253753","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568253753?lang=zh_cn&edition=full","pubTime":"2025-09-19 16:15","pubTimestamp":1758269723,"startTime":"0","endTime":"0","summary":"09月19日, 盛禾生物-B股价跌2.04%，报收7.70元，成交金额24.4万元，换手率0.02%，振幅8.65%，量比1.46。盛禾生物-B今日主力资金净流出16.0万元，上一交易日主力净流出0万元。该股近5个交易日上涨0.52%，主力资金累计净流出16.0万元；近20日主力资金累计净流出23.4万元，其中净流出天数为2日。该股主力净额占比0.01%，港股市场排名2352/2671。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919161730a436b749&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919161730a436b749&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02898"],"gpt_icon":0},{"id":"2567116833","title":"盛禾生物-B(02898)：德勤辞任公司核数师","url":"https://stock-news.laohu8.com/highlight/detail?id=2567116833","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567116833?lang=zh_cn&edition=full","pubTime":"2025-09-15 19:15","pubTimestamp":1757934907,"startTime":"0","endTime":"0","summary":"智通财经APP讯，盛禾生物-B(02898)发布公告，德勤‧关黄陈方会计师行(德勤)已提呈其日期为2025年9月9 日的辞任函件(辞任函件)，德勤已辞任本公司核数师(核数师)一职，即时生效，原因为本公司未能就审核本公司及其附属公司(本集团)截至2025年 12月31日止年度的综合财务报表的审核费用与德勤达成共识。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1345402.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02898"],"gpt_icon":0},{"id":"2564582391","title":"盛禾生物-B盘中异动 股价大跌12.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2564582391","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564582391?lang=zh_cn&edition=full","pubTime":"2025-09-03 13:49","pubTimestamp":1756878590,"startTime":"0","endTime":"0","summary":"2025年09月03日下午盘13时49分，盛禾生物-B股票出现波动，股价急速下挫12.04%。截至发稿，该股报6.940港元/股，成交量600股，换手率0.00%，振幅0.13%。盛禾生物-B股票所在的生物技术行业中，整体涨幅为1.17%。其相关个股中，创胜集团-B、圣诺医药-B、三叶草生物-B涨幅较大，振幅较大的相关个股有创胜集团-B、三叶草生物-B、圣诺医药-B，振幅分别为31.41%、26.45%、26.39%。IAH0968是一种抗体依赖性细胞介导的细胞毒性增强型单株抗体,IAP0971及IAE0972均为抗体细胞激素。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250903134950a4b11ae9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250903134950a4b11ae9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02898"],"gpt_icon":0},{"id":"2563021102","title":"盛禾生物-B(02898)公布中期业绩 净亏损3819.9万元 同比增长5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563021102","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563021102?lang=zh_cn&edition=full","pubTime":"2025-08-29 21:59","pubTimestamp":1756475970,"startTime":"0","endTime":"0","summary":"智通财经APP讯，盛禾生物-B(02898)公布2025年中期业绩，其他收入503.5万元，同比增长182.55%;净亏损3819.9万元，同比增长5.88%;每股亏损0.25元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1339105.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"盛禾生物-B(02898)公布中期业绩 净亏损3819.9万元 同比增长5.88%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02898","BK1161"],"gpt_icon":0},{"id":"2517505109","title":"盛禾生物-B03月07日主力净流出5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2517505109","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517505109?lang=zh_cn&edition=full","pubTime":"2025-03-07 16:17","pubTimestamp":1741335429,"startTime":"0","endTime":"0","summary":"03月07日, 盛禾生物-B股价跌5.35%，报收3.89元，成交金额7万元，换手率0.01%，振幅4.87%，量比6.56。盛禾生物-B今日主力资金净流出5万元，上一交易日主力净流出0万元。该股近5个交易日下跌7.60%，主力资金累计净流出5万元；近20日主力资金累计净流出5万元，其中净流出天数为1日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307170958abecca1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307170958abecca1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02898","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.longruntea.com","stockEarnings":[{"period":"1week","weight":0.0209},{"period":"1month","weight":-0.0261},{"period":"3month","weight":-0.1859},{"period":"6month","weight":-0.1277},{"period":"1year","weight":0.5564},{"period":"ytd","weight":-0.0437}],"compareEarnings":[{"period":"1week","weight":-0.0302},{"period":"1month","weight":0.0038},{"period":"3month","weight":0.0121},{"period":"6month","weight":0.0684},{"period":"1year","weight":0.2713},{"period":"ytd","weight":0.0363}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"Sunho Biologics Inc是一家主要从事生物技术的研发和生产的公司。该公司主要从事发现、开发和商业化生物制剂，通过直接调节先天性和适应性免疫系统来调节免疫微环境。该公司拥有三种核心产品，即IAH0968、IAP0971及IAE0972。IAH0968是一种抗体依赖性细胞介导的细胞毒性增强型单克隆抗体，IAP0971及IAE0972均为抗体细胞因子。","yearOnYearQuotes":[{"month":1,"riseRate":0.357143,"avgChangeRate":-0.038899},{"month":2,"riseRate":0.4,"avgChangeRate":-0.004403},{"month":3,"riseRate":0.357143,"avgChangeRate":0.015388},{"month":4,"riseRate":0.333333,"avgChangeRate":0.011323},{"month":5,"riseRate":0.333333,"avgChangeRate":0.036651},{"month":6,"riseRate":0.266667,"avgChangeRate":0.072908},{"month":7,"riseRate":0.266667,"avgChangeRate":-0.002222},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.068577},{"month":9,"riseRate":0.214286,"avgChangeRate":-0.012573},{"month":10,"riseRate":0.266667,"avgChangeRate":0.020492},{"month":11,"riseRate":0.466667,"avgChangeRate":0.037807},{"month":12,"riseRate":0.4,"avgChangeRate":0.03045}],"exchange":"SEHK","name":"盛禾生物-B","nameEN":"SUNHO BIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"盛禾生物-B(02898)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供盛禾生物-B(02898)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"盛禾生物-B,02898,盛禾生物-B股票,盛禾生物-B股票老虎,盛禾生物-B股票老虎国际,盛禾生物-B行情,盛禾生物-B股票行情,盛禾生物-B股价,盛禾生物-B股市,盛禾生物-B股票价格,盛禾生物-B股票交易,盛禾生物-B股票购买,盛禾生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"盛禾生物-B(02898)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供盛禾生物-B(02898)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}